Cancer Treatment News and Research

RSS

NCCN guidelines establish an equitable standard of care for cancer outcomes

Today, the National Comprehensive Cancer Network® (NCCN®) - an alliance of leading cancer centers - convened a policy summit to examine how geography impacts cancer outcomes.

16 Jun 2023

Older breast cancer survivors show greater epigenetic aging than same-aged people without cancer

In a new multi-center study, researchers from the Medical College of Wisconsin (MCW) joined with leading cancer centers from across the nation to examine whether cancer and its treatments accelerate aging.

14 Jun 2023

OICR funding to help six Ontario-based research teams improve the lives of cancer patients

Funding announced today by the Ontario Institute for Cancer Research (OICR) will help six Ontario-based research teams pursue their ultimate goal of improving the lives of people with cancer.

14 Jun 2023

NCCN introduces new global resource to improve thyroid cancer care in low- and middle-income countries

The National Comprehensive Cancer Network® (NCCN®) is introducing a new global resource to improve thyroid cancer care in low- and middle-income countries at the upcoming World Congress on Thyroid Cancer, in London. During the event, NCCN Senior Vice President and Chief Medical Officer, Wui-Jin Koh, MD, will present on NCCN's ongoing global work to define and advance high-quality, high-value, patient-centered cancer care.

14 Jun 2023

Mark Cuban's Cost Plus Drug Company projects huge savings over Medicare for generic cancer medications

Researchers reveal significant cost savings when generic oncology drugs are purchased through the Mark Cuban Cost Plus Drug Company.

13 Jun 2023

Automated liquid biopsy test predicts early disease progression, survival among patients with metastatic breast cancer

A novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can be used to predict early disease progression and potential survival among patients with metastatic breast cancer in as little as one month after starting treatment, according to a recent study.

13 Jun 2023

Intelligent wound dressing material could bring pain relief to burn patients

One of the challenges in treating burn victims is the frequency of dressing changes, which can be extremely painful. To bring relief to this and other problems, University of Waterloo researchers have created a new type of wound dressing material using advanced polymers.

10 Jun 2023

Global trials could save lives by changing treatment procedure for cancer in the future

Researchers from Edith Cowan University (ECU) are leading ground-breaking global trials which could save lives by changing how we treat cancer in the near future.

9 Jun 2023

Insilico Medicine nominates pan-TEAD inhibitor as a potential solution for drug resistance in solid tumor patients

Insilico Medicine, a generative artificial intelligence (AI)-driven clinical-stage drug discovery company, today announced the nomination of ISM6331, a potential best-in-class pan-TEAD inhibitor, as a preclinical candidate compound (PCC) generated by Chemistry42, its proprietary generative chemistry-driven molecule design engine, targeting the Hippo pathway for the treatment of advanced solid tumors.

8 Jun 2023

Study: Functional limitations among US cancer survivors more than doubled over the past 20 years

The percentage of survivors of cancer reporting functional limitations in the United States has more than doubled over the past 20 years, according to a new study in the journal JAMA Oncology.

7 Jun 2023

Promising targeted therapy offers new hope to certain patients with advanced pancreatic cancer

A promising new targeted cancer therapy will soon be available to certain patients with advanced pancreatic cancer – from the comfort of their home.

7 Jun 2023

New folate-targeting magnetic microrobot system shows great potential in cancer treatment

The limited ability of microrobots to assist drugs in entering cells hinders their therapeutic efficacy. To address this, the cancer-targeting molecule folic acid (FA) was introduced to microrobots to promote drug uptake by cancer cells via receptor-ligand-mediated endocytosis.

6 Jun 2023

New type of wound dressing could enhance the healing process for burn patients

One of the challenges in treating burn victims is the frequency of dressing changes, which can be extremely painful.

6 Jun 2023

Expertise in cancer treatment could be used to find a cure for endometriosis

Endometriosis: If we utilize all the knowledge we have about cancer, there is reason to hope that effective diagnosis and treatments can be developed to combat the female condition 'everybody' is talking about.

5 Jun 2023

Fred Hutch experts highlight research on cancer treatment advances, survivorship and precision oncology at ASCO

At the 2023 American Society for Clinical Oncology Annual Meeting—to be held June 2-6 in Chicago, Illinois—Fred Hutchinson Cancer Center experts will present research spanning survivorship, advances in treatments and clinical trials, how access to cancer care affects outcomes, integrative medicine and more.

5 Jun 2023

Researchers characterize a unique molecular mechanism of early stages of programmed cell death

Researchers have for the first time characterized a unique molecular mechanism of the early stages of programmed cell death or apoptosis, a process which plays a crucial role in prevention of cancer.

2 Jun 2023

Study finds substantial differences in cancer drug funding decisions across high-income countries

Despite the use of similar assessment criteria when deciding whether new cancer drugs should receive funding, there are substantial differences in drug funding decisions, across comparable high-income countries.

2 Jun 2023

NCI launches new initiative to test new drug combinations that target specific tumor alterations

The National Cancer Institute (NCI) has launched a large precision medicine cancer initiative to test the effectiveness of treating adults and children with new drug combinations that target specific tumor alterations.

1 Jun 2023

NCCN collaborates with K Hospital and Vietnam Cancer Association to improve standards for cancer care

he National Comprehensive Cancer Network - a not-for-profit alliance of leading cancer centers in the United States - today announced the signing of a Memo of Understanding (MOU) with Vietnam National Cancer Hospital ("K Hospital") and the Vietnam Cancer Association to work together to improve standards for cancer care throughout the country.

1 Jun 2023

New data guides treatment choices for patients with r/r lymphoma during pregnancy

Today, Blood Advances published a study revealing that patients with relapsed/refractory (r/r) lymphoma during pregnancy experienced a progression-free survival rate of 24% and an overall survival rate of 83%.

1 Jun 2023

Cancer Treatment News and Research

NCCN guidelines establish an equitable standard of care for cancer outcomes

Older breast cancer survivors show greater epigenetic aging than same-aged people without cancer

OICR funding to help six Ontario-based research teams improve the lives of cancer patients

NCCN introduces new global resource to improve thyroid cancer care in low- and middle-income countries

Mark Cuban's Cost Plus Drug Company projects huge savings over Medicare for generic cancer medications

Automated liquid biopsy test predicts early disease progression, survival among patients with metastatic breast cancer

Intelligent wound dressing material could bring pain relief to burn patients

Global trials could save lives by changing treatment procedure for cancer in the future

Insilico Medicine nominates pan-TEAD inhibitor as a potential solution for drug resistance in solid tumor patients

Study: Functional limitations among US cancer survivors more than doubled over the past 20 years

Promising targeted therapy offers new hope to certain patients with advanced pancreatic cancer

New folate-targeting magnetic microrobot system shows great potential in cancer treatment

New type of wound dressing could enhance the healing process for burn patients

Expertise in cancer treatment could be used to find a cure for endometriosis

Fred Hutch experts highlight research on cancer treatment advances, survivorship and precision oncology at ASCO

Researchers characterize a unique molecular mechanism of early stages of programmed cell death

Study finds substantial differences in cancer drug funding decisions across high-income countries

NCI launches new initiative to test new drug combinations that target specific tumor alterations

NCCN collaborates with K Hospital and Vietnam Cancer Association to improve standards for cancer care

New data guides treatment choices for patients with r/r lymphoma during pregnancy

Your guide to microplate readers for cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News